Rigel Pharmaceuticals (RIGL) Cash from Investing Activities (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Rigel Pharmaceuticals | 696.99 Mn | 550.30 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.56% |
| Dec 31, 2025 | 23.55% |
| Sep 30, 2025 | -42.53% |
| Jun 30, 2025 | -120.58% |
| Mar 31, 2025 | 3.32% |
| Dec 31, 2024 | -387.06% |
| Sep 30, 2024 | -65.21% |
| Jun 30, 2024 | 3,391.69% |
| Mar 31, 2024 | 104.55% |
| Dec 31, 2023 | -487.52% |
| Sep 30, 2023 | -139.39% |
| Jun 30, 2023 | 282.24% |
| Mar 31, 2023 | -95.82% |
| Dec 31, 2022 | 77.89% |
| Sep 30, 2022 | -50.44% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | 248.78% |
| Dec 31, 2021 | 114.61% |
| Sep 30, 2021 | 10.60% |
| Jun 30, 2021 | -759.31% |